Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Bevacizumab
×
Genitourinary
×
Clear all
Filters
3
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled
NCT03961698
2023-08-14
MARIO-3
Infinity Pharmaceuticals, Inc.
Phase 2
Unknown
91 enrolled